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Dear Editor,
Lipodystrophies (LDs) are a heterogeneous group of genetic
and acquired disorders that mainly affect women. They are
characterised by total or partial loss of subcutaneous adipose
tissue (lipoatrophy), which may be associated with accumula-
tion of fat (lipohypertrophy) in different regions of the body.
Patients with LDs have extreme insulin resistance, hyper-
glycaemia, severe hypertriglyceridaemia, low HDL levels and
fatty liver. The seriousness of these metabolic complications
is correlated with the extent of fat loss.1,2
There are 2 hereditary forms:
- Generalised lipodystrophy, which has an autosomal reces-
sive inheritance pattern and is characterised by total loss of
subcutaneous adipose tissue, and
- Congenital partial lipodystrophy, the more  common form,
which has an autosomal dominant inheritance pattern and
is linked to partial loss of adipose tissue.3
Several researchers have noted that the metabolic abnor-
malities observed are due to a failure in the functions of
regulation of fatty acid storage and release of adipose tis-
sue. There are also genes involved in the effector actions of
insulin, and in adipocyte proliferation and differentiation. Dif-
ferent candidate genes have been analysed, such as the insulin
receptor gene, the insulin receptor substrate 1 gene and the
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beta-2 adrenergic receptor gene.4 The lack of subcutaneous
adipose tissue deposits is due to the low concentration of lep-
tin. Hypoleptinaemia alters the hunger/satiety signals in the
central nervous system and causes hyperphagia. Then, caloric
excess causes fat to accumulate in the muscles and liver and
triggers severe insulin resistance, diabetes with high insulin
requirements and hypertriglyceridaemia, which creates a high
risk of pancreatitis. Patients with LDs also have fatty liver,
myocardiopathies and proteinuric nephropathies.5
A 41-year-old female patient with a diagnosis of con-
genital partial lipodystrophy, diabetes diagnosed at age 15,
being treated with insulin aspart (115 IU/day), with poor gly-
caemic control, who had bilateral proliferative retinopathy
and end-stage renal disease secondary to membranoprolifer-
ative glomerulonephritis type I (by renal punch biopsy [RPB]),
in haemodialysis three times per week since April 2012. In
addition, she had mixed dyslipidaemia being treated with
atorvastatin 20 mg/day and fenoﬁbrate 200 mg/day and HTN.
Physical examination (PE): dry weight 66.500 kg; height 170 cm;
BMI: 23.01; BP 160/70.
Her limbs looked thin, with loss of subcutaneous fat in
the buttocks, thighs and upper limbs. Hypotrophic breasts,
slight hepatomegaly, acanthosis nigricans on the neck and
hirsutism.
It was decided to place her on the waiting list for a, Giunippero A, et al. Trasplante simultáneo de rin˜ón y páncreas
;36:450–451.
in dialysis and her diabetes without insulin resistance,
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iven her C-peptide level below one and her expected
reatment with recombinant human leptin, requested for
ompassionate use. She received a double kidney–pancreas
ransplant on 07/09/2015, with an intestinal bypass. She
lso received induction with ATG-Fresenius (anti-human
-lymphocyte immunoglobulin from rabbits) (15 mg/kg
ivided into 5 doses), antibacterial prophylaxis for 5 days
ith piperacillin/tazobactam, an antifungal agent for one
onth, an anti-cytomegalovirus (CMV) agent (for 3 months)
nd an anti-pneumocystis pneumonia (PCP) agent for 2
ears. Maintenance immunosuppression was added with
elatacept (de novo) and tacrolimus/Deltisona (methyl-
rednisolone)/mycophenolate sodium. The indication for
elatacept was due to the patient’s vascular/metabolic risk
nd to initial efforts to decrease the dose of tacrolimus
relative to the standard dose) to later suspend it in the long
erm. The grafts functioned immediately; neither insulin
or haemodialysis was required. In the postoperative period,
he patient had intercurrent intestinal obstruction with an
nastomosis ﬁstula, which required conversion to a new
oux-en-Y duodenojejunostomy. She also had a low-output
ancreatic ﬁstula, which closed without complications.
urrently, the patient has normal renal and pancreatic
unction, with the following values: fructosamine 237 mol/l
normal level [NL] 285 mol/l), HbA1c 4.6% (NL 2.5%–5.9%),
-peptide 1.8 ng/ml (NL 0.5–2 ng/ml), creatinine 0.8 mg/dl (NL
.8–1.4 mg/dl) and no proteinuria. Tacrolimus levels of 6 ng/ml
re being maintained.
This is the ﬁrst report of a double kidney–pancreas trans-
lant with a favourable course in a patient with congenital
artial lipodystrophy and a new immunosuppressant regi-
en.
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ear Editor,e  present the case of a 76-year-old patient with primary
jogren’s syndrome (pSS) and mild acute renal failure with
ctive sediment. Prior medical history included hypertension
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phropathy.  Signiﬁcance  of
xta.  La  importancia  de  la
well controlled with 2 drugs and pSS with glandular
(biopsy) and extraglandular involvement (pulmonary ﬁbro-aparros G, Mun˜oz Vico J, Gómez Morales M. Síndrome de Sjogren
. Nefrologia. 2016;36:451–453.
sis, skin purpura and Raynaud’s disease that required
treatment with steroids), being treated with azathioprine,
prednisone 5 mg/day, biphosphonate, calcium/vitamin D,
